CRL vs LDWY · rev $2.00B vs rev $37.8M
Charles River Laboratories (CRL) versus Lendway Inc. (LDWY) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Lendway Inc. (LDWY) is a advertising agencies company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported LDWY revenue for 2024-12-31 was $37.8M. Net income was -$6.7M. Revenue was up 100.9% from 2022-12-31 to 2024-12-31. LDWY currently screens at market cap $9.3M.
CRL currently screens at market cap $7.78B. LDWY currently screens at market cap $9.3M.
Not investment advice. Open the CRL and LDWY stock pages for the full models.
Not investment advice.